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Altered cellular bioenergetics and mitochondrial
function are major features of several diseases,
including cancer, diabetes, and neurodegenerative
disorders. Given this important link to human health,
we sought to define proteinswithinmitochondria that
are critical for maintaining homeostatic ATP levels.
We screened an RNAi library targeting >1,000
nuclear-encoded genes whose protein products
localize to the mitochondria in multiple metabolic
conditions in order to examine their effects on cellular
ATP levels. We identified a mechanism by which
electron transport chain (ETC) perturbation under
glycolytic conditions increased ATP production
through enhanced glycolytic flux, thereby high-
lighting the cellular potential for metabolic plasticity.
Additionally, we identified a mitochondrial adenylate
kinase (AK4) that regulates cellular ATP levels and
AMPK signaling and whose expression significantly
correlates with glioma patient survival. This study
maps the bioenergetic landscape of >1,000 mito-
chondrial proteins in the context of varied metabolic
substrates and begins to link key metabolic genes
with clinical outcome.INTRODUCTION
The production of ATP in order to fuel energy-consuming pro-
cesses is a principal function of both quiescent and proliferative
cellular metabolism. Sufficient energy levels must be maintained
for cells to thrive (Wallace, 2011), and it is clear that dysregulated
bioenergetics plays an important role in many diseases (Rai-
mundo, 2014). In cancer, energy production is increased to sup-
port rapid proliferation (Formentini et al., 2010; Vander Heiden
et al., 2009, 2012), while in many neurodegenerative diseases,
core energy-producing pathways are compromised, leading toimpaired cellular function and decreased viability (Breuer et al.,
2013; Federico et al., 2012; Xun et al., 2012).
The major pathways directly responsible for ATP production
in quiescent and proliferative cells are well described. Mito-
chondria house much of the core ATP-generating machinery
and are recognized as important for maintaining cellular energy
homeostasis through integrating cellular environmental and
nutritional signals to produce the bulk of cellular ATP. However,
the individual contributions to cellular energy homeostasis by
each mitochondrial protein and the numerous mitochondrial
noncellular respiration functions have not been comprehen-
sively investigated. Establishing a catalog of each protein’s
impact on the cellular metabolic economy would provide a
useful reference for investigating normal and disease bio-
energetics (Pagliarini and Rutter, 2013). Because cells respond
to different fuel sources by utilizing different bioenergetic
programs (Stanley et al., 2014), defining these bioenergetic
contributions in the context of multiple fuel sources provides
added biological relevance.
Previous studies have identified the contributions of individual
metabolic genes to cancer cell survival (Ros et al., 2012) or tumor
formation (Possematoet al., 2011), identifieddrugs that areeffec-
tive in distinct bioenergetic programs (Gohil et al., 2010),mapped
proteomic components of mitochondria (Pagliarini et al., 2008;
Rensvold et al., 2013;Rheeet al., 2013), or derived computational
models of central carbon metabolism (Greenberg et al., 2011;
Noor et al., 2010; Shlomi et al., 2011). In this study, we developed
ahigh-throughputmethod in order to identify critical components
regulating cellular ATP levels in specific metabolic programs and
performed a functional RNAi screen to characterize cellular
bioenergetics under glycolytic and oxidative phosphorylation
(OXPHOS) conditions. We analyzed the entire complement of
MitoCarta genes (a catalog of >1,000 genes whose protein prod-
ucts localize to themitochondria) (Pagliarini et al., 2008) for global
effects on cellular energy levels in response to four fuel sources
(glucose, pyruvate, glutamine, and galactose). In addition to
cataloging each gene, our study identified specificmitochondrial
functions associated with maintaining ATP levels in distinct fuel
sources, as cultured cells are able to utilize a variety of carbon
sources for bioenergetic requirements (Genzel et al., 2005;Cell Reports 7, 907–917, May 8, 2014 ª2014 The Authors 907
Figure 1. A Sensitized RNAi Screen to
Identify Regulators Glycolytic and OXHPOS
Bioenergetics
(A) Depiction of the nutrient source strategy
utilized in this study.
(B) Relative ATP/cell measurements from cells
after a 4 hr treatment with DMSO, iodoacetic acid
(IAA, 10 mM), or rotenone (500 nM). Error bars
represent SD values.
(C) Compliment of metabolic pathways and func-
tions targeted in the RNAi screen.
(D) RNAi screen results. Labeled data points indi-
cate siRNAs that increased or decreased ATP
levels 25% ormore compared to control siRNAs in
all four conditions.
See also Figure S1.Reitzer et al., 1979).We also identified amechanism ofmetabolic
plasticity wherein genetic or chemical disruption of the electron
transport chain (ETC) significantly increased overall ATP levels
through enhanced glycolytic flux. Finally, we characterized ad-
enylate kinase 4 (AK4), the gene most significantly associated
with increased ATP production in our screen. Adenylate kinases
are critical regulators of adenine nucleotide homeostasis, main-
taining proper cellular AMP/ADP/ATP ratios (Dzeja and Terzic,
2009; Noma, 2005). As one of three mitochondrial adenylate
kinases, little is known about AK4 function. AK4 has been pro-
posed to play a role in cellular stress responses (Edhager et al.,
2014; Kong et al., 2013; Liu et al., 2009) and the invasive potential
of lung cancer cell lines (Jan et al., 2012). We found that AK4 reg-
ulates ATP levels across multiple cell types and cellular prolifera-
tion and is also associated with glioma patient survival. Remark-
ably, AK4 knockdown also activated the AMP-activated protein
kinase (AMPK)-signaling pathway, providing a mechanistic link908 Cell Reports 7, 907–917, May 8, 2014 ª2014 The Authorsbetween mitochondrial adenylate kinase
function and important energy-sensing
pathways.
RESULTS
Segregation of Cellular
Bioenergetic Programs
To restrict cells to different bioenergetic
contexts, we cultured cells in media con-
taining specified carbon nutrient sources
that forced reliance on either glycolysis or
OXPHOS for ATP production (Guppy
et al., 2002; Stanley et al., 2014). We
restricted cells to glucose as a model of
glycolytic bioenergetics, to either pyru-
vate or glutamine as different models of
common OXPHOS bioenergetics, and to
galactose as a model of bioenergetics
reliant on both glycolysis and OXPHOS
(Figure 1A) (Colombo et al., 2011; Gohil
et al., 2010; Hensley et al., 2013; Marro-
quin et al., 2007; Robinson et al., 1992;
Rossignol et al., 2004).To validate our strategy of restricting cells to glycolytic or
OXPHOS bioenergetic programs, we treated cells with inhibitors
of glycolysis (iodoacetic acid [IAA], which inhibits GAPDH) or OX-
PHOS (rotenone, which inhibits respiratory complex I). ATP
levels (ATP/cell; Figure S1A; see the Experimental Procedures)
in cells maintained in glucose and galactose media were
sensitive to acute glycolytic inhibition with IAA, whereas ATP
production in cells maintained in pyruvate, glutamine, or galac-
tose media were sensitive to acute OXPHOS inhibition with rote-
none (Figure 1B), as expected based on previous studies (Gohil
et al., 2010; Marroquin et al., 2007; Rossignol et al., 2004;
Warburg et al., 1967). ATP levels in cells grown in complete (Fig-
ure S1B) or glucose-only media were insensitive to OXPHOS
inhibition, indicating that HeLa cells preferentially rely on glycol-
ysis, even in the presence of OXPHOS-permissive carbon
substrates (Warburg, 1956). In the absence of glucose, how-
ever, HeLa cells retain the ability to utilize OXPHOS-specific
Table 1. Mitochondrial Proteins Impacting Cellular Bioenergetics
siRNAs altering ATP levels by R25% in multiple metabolic conditions. Red, green, blue, and yellow circles represent R25% ATP/cell changes in
glucose, pyruvate, glutamine, and galactose conditions, respectively. Percentages are the combined averages of ATP/cell changes in the indicated
metabolic conditions.bioenergetics, as they are viable and proliferate in OXPHOS-
restricted media conditions. These results of acute metabolic in-
hibition confirm our approach of utilizing alternative fuel sources
to restrict cells to specific bioenergetic programs. The metabolic
plasticity of the HeLa cell model revealed here also highlights the
challenges of targeting cancer cell bioenergetics as a therapeu-
tic strategy.
Identification of Mitochondrial Genes that Regulate
Cellular ATP Levels
Next, we used this strategy to interrogate a set of nuclear-
encoded genes that comprises >1,000 known mitochondria-
localized proteins (Figures 1C andS1C; Table S1).We performed
duplicate RNAi screens targeting these genes in each of the four
carbon sources (glucose, pyruvate, glutamine, and galactose).
Our results identified genes whose knockdown altered ATP
levels acrossmultiple conditions in addition to unique sets of bio-
energetic regulators for each condition (Figure 1D; Table S2).
Knockdown of five gene products (AK4, ADCK2, CASP8,
MECR, and TMEM70) increased ATP levels in all conditions,
while knockdown of six gene products (DNAJC11, VDAC2,
FAM65C, C12ORF62, HSCB, and APEX2) decreased ATP levels
in all conditions. Because these genes altered ATP levels in all
four nutrient conditions, the respective functions of their protein
products likely affect mechanisms that commonly impact ho-
meostatic ATP levels. Knockdown of additional genes altered
ATP levels byR25% in at least two or three of the four conditions
examined (Table 1). Importantly, each metabolic condition con-
tained unique genes whose knockdown impacted ATP levels in
only that nutrient source (Table S3). Taken together, these results
identify mitochondrial proteins that maintain cellular ATP levelsacross multiple metabolic conditions as well as mitochondrial
proteins that uniquely regulate ATP levels in specific metabolic
conditions.
We next defined mitochondrial functions that impact ATP
levels by grouping genes whose knockdown altered ATP levels
into common mitochondrial functions (Figure 2; Table S3). In
each of the four conditions, knockdown of genes associated
with the ETC, fatty acid metabolism, amino acid metabolism,
membrane transporters, and ribosomal proteins altered ATP
levels. However, a comparison of the overall effect on each func-
tion revealed opposing effects in glucose and galactose
compared to pyruvate and glutamine conditions (Figure S2A).
This may reflect the common routes of carbon flux into mito-
chondria in response to these fuels. Glucose and galactose car-
bons must flux through the glycolytic pathway prior to delivery
into mitochondria, while pyruvate and glutamine can be directly
imported into the mitochondria and incorporated into the tricar-
boxylic acid (TCA) cycle after only two enzymatic modifications.
Interestingly, as opposed to a comparison between functions,
gene-by-gene comparisons revealed that galactose and pyru-
vate conditions are more similar than galactose and glucose
conditions (Figure S2B), which is expected based on the results
of previous studies (Gohil et al., 2010; Marroquin et al., 2007;
Rossignol et al., 2004; Warburg et al., 1967). In addition to these
mitochondrial functions commonly affecting ATP levels across
all metabolic conditions, each condition also contains unique
mitochondrial functions. Redox maintenance genes are associ-
ated with pyruvate-specific bioenergetics, translocases are
associated with galactose-specific bioenergetics, mitochondrial
signaling proteins are associated with glutamine-specific bioen-
ergetics, and lipid metabolism, nucleotide metabolism, andCell Reports 7, 907–917, May 8, 2014 ª2014 The Authors 909
Figure 2. Mitochondrial Functions Impact-
ing Cellular Bioenergetics
Cytoscape (see the Experimental Procedures) was
used to define mitochondrial functions affecting
ATP levels in response to each metabolic condi-
tion. Central colored nodes represent individual
nutrient sources. Gray nodes radiating from the
central node represent all mitochondrial functions
associated with siRNAs altering ATP by R25%.
The distance between each functional node and
the central node is proportional to the number of
genes associated with that function that increased
or decreased ATP by R25% in that condition.
Functions with five or more associated genes
altering ATP byR25% are labeled and include the
associated genes, represented as nodes with
colored edges. Solid-colored edges represent
increased ATP levels; dotted edges represent
decreased ATP levels. The distance between each
gene node and the associated functional node is
proportional to themagnitude of ATP level change.
See also Table S3 and Figure S2.aminoacyl tRNA synthetases are associated with glucose-spe-
cific bioenergetics. Of note, many proteins with unknown func-
tions are associated with maintaining homeostatic ATP levels
in all conditions. Seventeen percent of the MitoCarta remains
uncharacterized, and these results reveal that many of these
uncharacterized proteins have a measurable impact on at least
one aspect of cell biology, providing an impetus for further char-
acterization of these proteins.
OXPHOS Inhibition Enhances Glycolytic ATP Production
We chose to pursue our observation that knockdown of ETC
genes produces opposite effects in glucose and pyruvate condi-
tions (Figure 2; Table S3). We mapped the effect of silencing
each ETC complex subunit on ATP levels. As expected, knock-
down of core ETC components negatively impacted ATP levels
in OXPHOS (pyruvate) conditions; surprisingly, however, we
found that knockdown of many core ETC components increased
glucose-dependent ATP levels (Figures 3A and 3B; Table S2). To
test whether acute perturbation of the ETC also elicited this
response, we treated cells with various chemical inhibitors of
the OXPHOS machinery for 4 hr. Chemical inhibition of the
OXPHOS machinery also increased glucose-dependent ATP
levels (Figures 3C and 1B), indicating that both acute (4 hr
chemical inhibition) and prolonged (72 hr knockdown) perturba-910 Cell Reports 7, 907–917, May 8, 2014 ª2014 The Authorstion of the OXPHOS machinery enhances
glucose-dependent ATP levels. Because
OXPHOS-dependent ATP production is
blocked in this context, we predicted
that the increased ATP levels could be
due to decreased ATP consumption or
increased glycolytic flux. To investigate
this, we labeled cells with D-[1,6-13C]-
glucose and concurrently measured
ATP levels and lactate production. We
found that knockdown of respiratory
complex I subunits as well as treatmentwith rotenone concomitantly increased ATP levels and lactate
production (Figures 3D and 3E), verifying an increase in glyco-
lytic flux and associated ATP production in this context. Interest-
ingly, prolonged perturbation (72 hr knockdown) resulted in
higher ATP and lactate levels than acute perturbation (4 hr rote-
none), indicating that this effect may lead to the accumulation of
metabolic products over time. It is well known that chemical
perturbation of the ETC increases glucose uptake and glycolytic
flux in order to counteract ATP depletion (Hardie et al., 2012;
Kurth-Kraczek et al., 1999; Marsin et al., 2000). However, in
this context, increased glycolytic flux has been observed, but
not necessarily increased ATP levels (Hao et al., 2010; Wu
et al., 2007).
Impact of the Mitochondrial Kinome and Phosphatome
on Cellular ATP Levels
We noted that silencing multiple mitochondrial kinases and
phosphatases affected ATP levels (Table S2), and it is known
that central metabolism can be regulated by phosphorylation
(Oliveira et al., 2012; Hornbeck et al., 2004). To investigate this
further, we rescreened the compliment of mitochondrial kinases
and phosphatases in quadruplicate in glucose and pyruvate con-
ditions and generated a volcano plot comparing ATP/cell fold
change to p values. Similar to the MitoCarta analysis, the
Figure 3. Suppression of OXPHOS in Glycolytic Conditions Increases Energy Production
(A) Electron transport chain schematic. Each subunit is colored according to the results of the RNAi screen in ATP/cell SDs from control siRNA.
(B) Results of the RNAi screen presented as percent change in ATP/cell for each subunit.
(C) Percent change in relative ATP/cell was determined compared to DMSO treatment. Measurements were obtained after 4 hr of treatment with ETC complex
inhibitors (n = 5 for each dose). Error bars represent SD values. *p < 0.05.
(D) Relative ATP/cell was measured in cells transfected with control or selected respiratory complex (RC) I subunit siRNAs and in cells treated with 500 nM
rotenone for 4 hr (n = 3 for each condition). Error bars represent SD values. **p < 0.01; ***p < 0.001.
(E) Glucose-to-lactate conversion in control and selected RC I subunit siRNA-transfected HeLa cells. Cells were cultured with medium containing 1,6 13C-labeled
glucose, and enrichment of 13C-lactate (m+3) in the extracellular medium was measured after 6 hr (n = 3 for each condition). Error bars represent SD values.
**p < 0.01; ***p < 0.001.adenylate kinase, AK4, and the uncharacterized phosphatase,
PPTC7, ranked highest in both conditions (Figure 4A), increasing
cellular ATP levels from 30% to 50% (Figure 4B). It is possible
that the mitochondrial kinome and phosphatome may regulate
ETC-mediated ATP production via phosphorylation (Acin-Perez
et al., 2011; Hopper et al., 2006; Pagliarini and Dixon, 2006).Indeed, by mining publically available databases for evidence
of phosphorylation of ETC complex subunits (Hornbeck et al.,
2004), we identified 284 reported phosphorylation events on
the ETC machinery (Table S4). Because adenylate kinases cata-
lyze the transfer of a phosphate group between ATP, ADP, and
AMP (Dzeja and Terzic, 2009; Noma, 2005; Noma et al., 2001),Cell Reports 7, 907–917, May 8, 2014 ª2014 The Authors 911
Figure 4. Mitochondrial Kinome and Phosphatome Impact on ATP
Levels
(A) Volcano plot depicting the results of a second RNAi screen targeting the
mitochondrial kinome and phosphatome in glucose and pyruvate conditions.
(B) Relative ATP/cell was measured in cells transfected with control, AK4, or
PPTC7 siRNAs. Error bars represent SD values (n = 4 for each siRNA).
**p < 0.01.
(C) Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR)
were measured using a Seahorse Biosciences XFe96 Extracellular Flux
Analyzer. Values were normalized to cell number. Cells were cultured in 10mM
glucose, 1 mM pyruvate, and 1 mM glutamine. Error bars represent SD values
(n = 10 for each siRNA).it is unlikely that AK4 directly phosphorylates the ETCmachinery.
However, we found that knockdown of PPTC7 increased oxygen
consumption rate while having no effect on extracellular acidifi-
cation rate (Figure 4C), raising the possibility that PPTC7 nega-
tively regulates ETC activity. Future studies examining whether
PPTC7 regulates ETC activity and ATP levels by modifying
ETC machinery phosphorylation status are warranted.
Adenylate Kinase 4 Regulates ATP Levels and Energy-
Sensing Signaling Pathways
Adenylate kinases are known to maintain homeostatic ATP,
ADP, and AMP levels, and because AK4 was the top gene prod-
uct in both theMitoCarta (Figure 1) and themitochondrial kinome
(Figure 4) screens, we chose to further characterize its effects on
ATP levels and cell fate. Silencing AK4 increased ATP levels in
HeLa cells (Figure 5A) as well as several other cell lines, including
U20S osteosarcoma cells, U251 glioma cells, andHK2 immortal-
ized normal kidney cells (Figure 5B). In addition to increasing ATP
levels, AK4 knockdown increased cellular proliferation (Fig-912 Cell Reports 7, 907–917, May 8, 2014 ª2014 The Authorsure 5C). To determine whether AK4 is associated with clinical
significance, we interrogated publically available databases for
AK4 and found AK4 expression and copy number to be nega-
tively correlated with glioma patient survival (Figure 5D). Low
expression and copy number correlate with improved patient
survival, while high copy number correlates with decreased
probability of survival. These results confirm the biological rele-
vance of genes identified in our screen and implicate AK4 as a
potentially important gene for normal and diseased cell biology.
An increase in cellular ATP levels would be expected to impact
cellular energy charge (Hardie and Hawley, 2001; Oakhill et al.,
2012) as well as AMPK activation (Hardie, 2011; Mihaylova and
Shaw, 2011). To evaluate the effect of AK4 silencing on these pa-
rameters, we first measured ATP levels, the ADP/ATP ratio as a
measure of energy charge, and AMPK activation in different
metabolic conditions. As expected, cells maintained in glucose-
and pyruvate-specific conditions for 72 hr exhibited decreased
ATP levels, increased ADP/ATP ratios, and enhanced AMPK
activation (Figure 6A). Because AK4 knockdown increases ATP
levels, we predicted that AK4 knockdown would mitigate these
effects of decreased energy in glucose- and pyruvate-specific
conditions. However, AK4 knockdown increased the ADP/ATP
ratio in all conditions (Figure 6B). Accordingly, AK4 knockdown
also induced AMPK phosphorylation of AMPK at T172 in all con-
ditions examined (Figure 2C). AMPK is a master energy sensor,
responding to altered cellular energy charge by activating catab-
olism and inhibiting anabolism. Active AMPK phosphorylates
ULK1 at S555 to induce autophagy-mediated mitochondrial
and energetic homeostasis (Egan et al., 2011). We found that
AK4 knockdown induced ULK1 S555 phosphorylation, consis-
tent with AMPK activation status (Figure 6C). AMPKwas similarly
induced by AK4 knockdown in U20S and U251 cells (Figure 6D),
suggesting that normal AK4 function impacts AMPK activation
across multiple cell types. Together, these data implicate AK4
as an important regulator of cellular homeostasis through regu-
lation of cellular energy charge and AMPK activation.
DISCUSSION
The results described here provide a comprehensive assess-
ment of mitochondrial proteins involved in cellular bioenergetics.
Although some previous reports investigate the effects of meta-
bolic inhibitors on bioenergetics with respect to cell viability and
oxygen consumption and glycolytic rates (Giordano et al., 2012;
Gohil et al., 2010), our study maps the contributions of individual
mitochondrial proteins to ATP levels in response to four distinct
fuel sources. This analysis was performed in both glycolytic and
OXPHOS conditions, providing the relative contribution of each
protein in response to multiple fuel sources. While the work
described here does not comprehensively define all mitochon-
drial protein contributions to bioenergetics in all metabolic
environments, the approach and results generated by this study
provide a workable platform to expand our knowledge of cellular
bioenergetics on a large scale. Future studies using similar
approaches in a larger number of cell types and bioenergetic
substrates can add to our knowledge of the similarities and dif-
ferences in bioenergetic determinants between disparate cell
types and fuel sources. The etiology of many diseases includes
Figure 5. AK4 Controls ATP Levels, Proliferation, and Expression Levels Correlate with Glioma Patient Survival
(A and B) Relative ATP/cell was measured in cells transfected with control or AK4 siRNAs (n = 3 for each siRNA). Error bars represent SD values. **p < 0.01.
Western blot depicting the level of AK4 knockdown.
(C) Cell proliferationwasmeasured by xCELLigence RTCA. Cell densitymeasurements were taken every hour for 96 hr (n = 6 for each siRNA). Error bars represent
SD values.
(D) The Rembrandt database was used to perform a Kaplan-Meier survival analysis of glioma patients with differential AK4 expression and copy number.altered energetics and mitochondrial dysfunction, yet the ge-
netic basis for many of these diseases remains unknown. Impor-
tantly, this study will provide a valuable resource for identifying
the genetic determinants of altered mitochondrial-dependent
energetics. It provides additional rationale for identifying poten-
tial drug candidates for diseases that preferentially rely on spe-
cific metabolic programs (e.g., the relative contributions of
glycolytic and OXPHOS metabolic programs may vary between
cell and cancer type; Fan et al., 2013; Zu and Guppy, 2004).
Many of the specific genes and functions associated with
mitochondrial-dependent ATP levels in this study fit logically
within the current understanding of bioenergetics and mitochon-
drial biology. Knockdown of genes and functions that consume
ATP generally increased ATP levels (e.g., ATPases and vesicular
trafficking proteins), while knockdown of the mitochondrial ma-
chinery required for protein synthesis would be expected to
disrupt normal mitochondrial function and adversely affect ATP
levels in mitochondrial-dependent nutrient conditions. In agree-
ment with this, silencingmitochondrial ribosomal proteins gener-
ally decreased ATP levels in pyruvate and glutamine conditions.
However, in the glycolytic condition, which is able to maintain
normal ATP levels without OXPHOS (Figures 1B and 4), knock-
down of ribosomal proteins and tRNA synthetases increased
ATP levels. This likely reflects the fact that protein synthesis re-
quires ATP consumption, and decreasingmitochondrial-specificATP consumption in a context that does not require mitochon-
drial-dependent ATP production will tip the bioenergetic balance
toward an overall increase in cellular ATP levels. An overall com-
parison of commonly altered functions between the nutrient con-
ditions reveals a similarity between glucose and galactose and
between pyruvate and glutamine (Figure S2A). As mentioned
above, this may reflect the common routes by which these
carbon sources are incorporated intometabolic pathways. Alter-
natively, this may be similar to the situation described above
wherein inhibiting energetically expensive mitochondrial func-
tions in fuels that do not rely exclusively on OXPHOS leaves a
positive balance of ATP, while inhibiting these same functions
in fuels that exclusively rely onmitochondrial metabolism is detri-
mental to overall ATP balances. Future studies following carbon
flux in each of these conditions may shed additional light on the
mechanisms driving these observations.
The above observations concern comparisons of the fewmito-
chondrial functions whose perturbation commonly altered ATP
levels in all conditions. Interestingly, a gene-by-gene compari-
son shows that galactose and pyruvate conditions are more
similar than galactose and glucose conditions (Figure S2B),
which is a more commonly recognized comparison (Gohil
et al., 2010; Marroquin et al., 2007; Rossignol et al., 2004; War-
burg et al., 1967). This may again reflect the fact that the above
functions represent the common routes of metabolic flux sharedCell Reports 7, 907–917, May 8, 2014 ª2014 The Authors 913
Figure 6. AK4 Regulates Cellular Energy Charge and AMPK
Signaling
(A) ATP levels, ADP/ATP ratio, and phospho-AMPK were measured after 72 hr
in the indicated medias (n = 6 for each condition). Error bars represent SD
values.
(B) ADP/ATP ratio was measured in cells transfected with control or AK4
siRNAs (n = 3 for each condition). Error bars represent SD values.
(C and D) Western blot analyses of AMPK signaling pathway from cells
transfected with control or AK4 siRNAs. Blots are representative of three
independent experiments.
See also Figure S3.between galactose and glucose, while the overall metabolic
economy of galactose is more similar to pyruvate (OXPHOS)
on a gene-by-gene basis. It is also worth noting that we found
many uncharacterized proteins to be associated with significant
changes in ATP levels. The functional significance of a large
portion of proteins that localize to mitochondria is unknown.
This study provides the first step toward characterizing these
proteins.
Knockdown of genes from the TCA cycle did not consistently
alter ATP levels in our screen with the exception of the succinate
dehydrogenase complex, which also functions in the ETC. This is
perhaps due to the many well-known and recently described
biochemical routes by which cells can circumvent perturbations
of the TCA cycle (Cheng et al., 2011; DeBerardinis et al., 2007; Le
et al., 2012; Marin-Valencia et al., 2012; Metallo et al., 2012;
Mullen et al., 2012; Wise et al., 2011). However, an unanticipated
result of this study was the general increase in glycolytic bioen-
ergetics and flux observed upon knockdown or chemical inhibi-
tion of core OXPHOS machinery, a phenomenon essentially
opposite of the Crabtree effect (Crabtree, 1929; Diaz-Ruiz
et al., 2011). Potential explanations for this include an unidenti-
fied ETC-flux sensing mechanism that signals to accelerate
glycolytic flux upon ETC impairment. Alternatively, in the context
of ETC impairment, NADH levels may increase as a function of
reduced respiratory complex I activity. In this case, increasing
glycolytic flux and the conversion of pyruvate to lactate by914 Cell Reports 7, 907–917, May 8, 2014 ª2014 The Authorslactate dehydrogenase could serve to restore the NAD+/NADH
ratio. Each of these scenarios would provide cells a mechanism
for rapid adaptation in heterogeneous metabolic environments,
similar to the Crabtree effect. Additional studies comparing the
capacities of normal and diseased cells for this response may
provide valuable insight into the mechanistic basis of specific
diseases.
Phosphorylation is another potential mechanism by which
ETC activity may be regulated (Arachiche et al., 2008; Covian
and Balaban, 2012; Lee et al., 2005; Samavati et al., 2008).
Here, we compile the known phosphorylation sites on the core
ETC machinery and provide the relative contributions of the
mitochondrial kinome and phosphatome to ATP levels. Our
studies identify the uncharacterized phosphatase, PPTC7, as a
candidate for phosphoregulation of the ETC. Interestingly, while
thismanuscript was in preparation, the yeast homolog of PPTC7,
PTC7, was found to be associated with regulating ubiquinone
biosynthesis, and thus ETC activity, through dephosphorylating
the ubiquinone biosynthetic enzyme, Coq7 (Martı´n-Montalvo
et al., 2013).
We identified adenylate kinase 4 (AK4) as a key regulator of
cellular ATP levels and energy-sensing signaling pathways and
found it to be associated with glioma patient survival. It is unlikely
that the increase in ATP observed by AK4 knockdown is solely
due to a loss in mitochondrial adenylate kinase maintenance of
ATP, ADP, and AMP concentrations. Cells typically maintain
ATP, ADP, and AMP concentrations at ratios of 100:10:1,
respectively. Therefore, conversion of all ADP and AMP stores
to ATP would only raise ATP levels by approximately 10%, while
AK4 knockdown consistently increases ATP levels by more than
25%. Additionally, we find that AK4 knockdown concomitantly
increases the cellular ADP/ATP ratio, indicating that ADP (and
likely AMP) levels increase along with ATP. One possible expla-
nation is that AK4 loss and associated loss of mitochondrial
adenylate kinase function activates a feedback mechanism
that induces adenosine biosynthesis, effectively increasing all
adenosine nucleotide pools. Adenosine nucleotide biosynthesis
is known to affect AMPK activation status in flies (Stenesen et al.,
2013). Initial metabolic profiling experiments show a trend of
increased AMP and ADP upon AK4 knockdown, although this
trend is not statistically significant (Figure S3A). Our observations
that modulating AK4 levels impinges upon the energetic stress-
sensing AMPK pathway is also consistent with its proposed as-
sociation with cellular stress responses (Edhager et al., 2014;
Kong et al., 2013; Liu et al., 2009). In addition, we find AK4 to
be negatively correlated with glioma patient survival, in accor-
dance with an analysis of lung cancer expression profiles that
found high AK4 expression to correlate with poor patient survival
(Jan et al., 2012). This previous report suggested that AK4 regu-
lates gene transcription to mediate its effects on cancer cell
oncogenic potential, although the mechanism by which a mito-
chondrial adenylate kinase regulates gene transcription remains
unknown. Our findings raise the possibility that AK4’s impact on
bioenergetics and metabolism may contribute to cancer biology
by maintaining the proper balance of adenosine nucleotides and
other metabolites. Indeed, metabolic profiling revealed that
small interfering RNA (siRNA)-mediated depletion of AK4 alters
the cellular concentrations of several intermediates of central
carbon metabolism (Figure S3B). Altered utilization of central
carbon metabolites and switches in bioenergetic programs by
cancer cells are becoming recognized as critical components
of the oncogenic potential of many cancers (Hitosugi et al.,
2012; Locasale et al., 2011; Metallo and Vander Heiden, 2013;
Mullen et al., 2012; Oliva et al., 2010; Possemato et al., 2011;
Son et al., 2013); thus, AK4’s involvement in these processes
may represent its association with cancer patient survival.
Similar to the effects that we observe upon AK4 knockdown,
Snijder et al. recently reported that siRNA-mediated knockdown
of AK5 in HeLa cells also increased proliferation (Snijder et al.,
2012), and other groups have implicated nucleotide biogenesis
in oncogenic potential (Stenesen et al., 2013; Wawrzyniak
et al., 2013). Knockdown of additional nucleotide kinases in
our study also increased ATP levels (e.g., NME proteins). Thus,
regulation of nucleotide composition is an emerging area of inter-
est with respect to cellular bioenergetics and disease biology.
The results presented here provide a useful resource relating
individual mitochondrial proteins to cellular bioenergetics, iden-
tify a mechanism of metabolic adaptation, and identify AK4 as a
gene with a potentially important role in maintaining cellular en-
ergy levels and AMPK signaling.
EXPERIMENTAL PROCEDURES
A full explanation of all methods used can be found in Supplemental Experi-
mental Procedures.
RNAi Screen
Cells were transfected in each nutrient condition in duplicate with a pool of two
siRNAs per gene and subjected to CellTiter-Glo and CyQUANT assays 72 hr
after siRNA transfection. siRNA knockdown throughout the experiments pre-
sented here reduced target mRNA levels from 80% to 98% (Figure S1D).
Full experimental methods can be found in the Supplemental Experimental
Procedures.
ATP/Cell Measurements
Growth media was removed following treatments, and a room-temperature
solution of Cell Titer-Glo, Opti-MEM, and CyQUANT was immediately added
to each well. Luminescence and fluorescence readings were consecutively
taken after a 10 min room-temperature incubation.
Cytoscape
Cytoscape version 3.0.2 was used to visualize network connectivity (Cline
et al., 2007; Shannon et al., 2003).
Electron Transport Chain Phosphorylation Sites
Protein posttranslational modification data presented in Table S4 were
obtained from the online systems biology resource PhosphoSite on
September 10, 2013.
Proliferation Index
Real-time cell proliferation was determined using the xCELLigence system,
which utilizes an electric current to determine cellular attachment to an
electrode-containing plate. Cells were plated in glucose media in a 96-well
electrode-containing plate, allowed to enter exponential growth, and then
transfected with the indicated siRNAs. The electrical impedance, caused by
cell adhesion to the plate, is directly proportional to cell number and is numer-
ically reported.
[3-13C] Lactate Measurement
Lactate production was measured with gas-chromatography mass spectrom-
etry on media from cells cultured for 6 hr in glucose-free medium containingdialyzed fetal bovine serum supplemented with 10 mM D-[1,6-13C]-glucose
(Cambridge Isotope Labs). Full experimental methods can be found in the
Supplemental Experimental Procedures.
ADP/ATP Ratio Measurement
ApoSENSOR ADP/ATP Ratio Bioluminescent Assay from BioVision was used
according to the manufacturer’s specifications.
Antibodies and Immunoblotting
Cells grown in the indicated culture conditions were washedwith cold PBS and
harvested on ice in cold lysis buffer. After normalization of concentration, sam-
ples were then separated on Tris-glycine polyacrylamide gels, transferred to
nitrocellulose membranes, blocked, and probed with primary antibodies.
Membranes were incubated in enhanced chemiluminescent reagent, exposed
to film, and developed for signal.
Metabolomics
Sample Preparation
A total of 1.5ml of extraction solvent (mixture ofmethanol, chloroform, andwa-
ter) with internal standards is added to cell-culture plates, and cells are scraped
off from the plate and transferred to Eppendorf tubes. Sample tubes were
vortexed briefly, sitting on ice for 5 min, and then centrifuged at 15,000 3 g
for 5min. Supernatant containing metabolites were transferred to autosampler
vials for liquid-chromatography mass spectrometry analysis. A series of cali-
bration standards were prepared along with samples to quantify metabolites.
Liquid-Chromatography Mass Spectrometry Analysis
An Agilent 1200 chromatographer, Luna NH2 HILIC (hydrophilic interaction
chromatography) column was used for chromatographic separation with the
Agilent 6520 series time-of-flight mass spectrometer. Data were processed
by MassHunter workstation software version B.06.
Statistical Analysis
Data represent biological replicates and are depicted as means ± SD.
A Student’s t test was used to determine significance.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.03.065.
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